BOTALYS is a Belgian botanical-ingredients company that grows rare medicinal plants, starting with Korean ginseng, inside one of Europe's largest indoor vertical farms. Using a proprietary Biomimetic Indoor Farming method, it recreates the harsh wild conditions that make plants build up active compounds, harvesting ginseng in months rather than years and producing roots with unusually high concentrations of ginsenosides. Its ultra-pure, standardized extracts - led by the HRG80 ginseng ingredient - supply nutraceutical, cosmetic and pharmaceutical companies looking for traceable, contaminant-free botanicals.
MetaNovas (MetaNovas Biotech) is an AI-driven biotech company building a drug and disease discovery platform that compresses the slow, failure-prone front end of R&D. Its stack of proprietary engines - MetaNLP, MetaKG, MetaOmics and MetaPep - reads millions of scientific documents, maps biomedical knowledge, and designs bioactive peptides before anything reaches a lab bench. The company applies that science to longevity beauty, cosmeceuticals, medical aesthetics and functional foods, working with global brands while pursuing novel targets, drug repurposing and precision-formulated consumer health products.
Meijie Wang is the co-founder and CEO of MetaNovas, an AI-driven biotech that designs functional peptides for skincare, supplements and drug discovery. A former NVIDIA AI infrastructure engineer who built VR games and worked on AI at Stanford's School of Medicine, he now runs a Silicon Valley and Shanghai operation whose knowledge-graph platform aims to compress the decade-long hunt for new bioactive ingredients into something far shorter. MetaNovas counts L'Oreal, Beiersdorf, Haleon, Takeda and Unilever among its partners and raised a Series A led by GL Ventures.